EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Aptamers: Current Applications in Leukemia Diagnostics and Therapeutics

Bahareh Hosseinpour iD, Joshua O'Grady iD, Neda Mohaghegh iD, Julie Hamati, Erin M McConnell iD, William G Willmore iD, Alireza Hassani Najafabadi iD, Maria C DeRosa iD

Nucleic Acid Therapeutics · 01.08.2026 · 36 (4) · 187-201

DOI: 10.1177/21593337261458148 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nucleic Acid Therapeutics, online erschienen am 15.06.2026. Verfasst von Bahareh Hosseinpour und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Carleton University, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Leukemia, Aptamers, Nucleotide, SELEX Aptamer Technique, Biomarkers, Tumor. Die Arbeit nennt 135 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aptamers are single-stranded synthetic oligonucleotides that bind noncovalently to targets with high affinity and selectivity. They are generated through an in vitro selection process known as Systematic Evolution of Ligands by Exponential Enrichment. Aptamers show significant promise in cancer diagnostics and therapeutics due to their specificity, versatility, and tunable biochemical properties. Aptamers can be used to target cellular biomarkers, which are detectable molecules that can indicate specific physiological states of cells, organs, and organisms, making them valuable indicators for diseases. Clinical trials on therapeutic aptamers are providing further insight into their potential use. Leukemia is a hematological malignancy characterized by the uncontrolled proliferation of abnormal blood-forming cells, primarily affecting the bone marrow and peripheral blood. This review will highlight the applications of aptamers in relation to the diagnosis and treatment of leukemia. Novel research on leukemia-related aptamers will be presented along with future directions for aptamer-based diagnostic and therapeutic methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeukemiaAptamers, NucleotideSELEX Aptamer TechniqueBiomarkers, TumorHumansAnimals

Stichwörter der Autor:innen

SELEXaptamerbiomarkerscancerdiagnosticsleukemiatherapeutics

Substanzen

Aptamers, NucleotideBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Carleton University, Ottawa, Ontario, Canada.
  • Terasaki Institute, Los Angeles, California, USA.
  • Institute of Biochemistry, Faculty of Science, Carleton University, Ottawa, Ontario, Canada.
  • College of Pharmacy, University of Cincinnati, Ohio, USA.

ORCID-Profile: Bahareh Hosseinpour, Joshua O'Grady, Neda Mohaghegh, Erin M McConnell, William G Willmore, Alireza Hassani Najafabadi, Maria C DeRosa

Förderung

  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Hosseinpour, B., O'Grady, J., Mohaghegh, N., Hamati, J., McConnell, E. M., Willmore, W. G., Hassani Najafabadi, A., & DeRosa, M. C. (2026). Aptamers: Current Applications in Leukemia Diagnostics and Therapeutics. Nucleic Acid Therapeutics, 36(4), 187-201. https://doi.org/10.1177/21593337261458148

Vancouver

Hosseinpour B, O'Grady J, Mohaghegh N, Hamati J, McConnell EM, Willmore WG, et al. Aptamers: Current Applications in Leukemia Diagnostics and Therapeutics. Nucleic Acid Therapeutics. 2026;36(4):187-201. doi:10.1177/21593337261458148

BibTeX
@article{Hosseinpour2026,
  author = {Hosseinpour, Bahareh and O'Grady, Joshua and Mohaghegh, Neda and Hamati, Julie and McConnell, Erin M and Willmore, William G and Hassani Najafabadi, Alireza and DeRosa, Maria C},
  title = {Aptamers: Current Applications in Leukemia Diagnostics and Therapeutics},
  journal = {Nucleic Acid Therapeutics},
  year = {2026},
  volume = {36},
  number = {4},
  pages = {187--201},
  doi = {10.1177/21593337261458148}
}
Kostenlos starten →